title: What are the clinical benefits of recombinant gonadotrophins?: the development of recombinant FSH (Puregon((R))): a scientific business.
authors.affiliation: Organon Laboratories Ltd, Science Park, Milton Road, Cambridge CB4 0FL, UK, and NV Organon, Oss, The Netherlands.
authors.forename: H J
authors.initials: HJ
authors.lastname: Out
authors.forename: H J
authors.initials: HJ
authors.lastname: Bennink
authors.forename: W N
authors.initials: WN
authors.lastname: de Laat
mesh_terms: D002986:Clinical Trials as Topic; D005260:Female; D005640:Follicle Stimulating Hormone / Q000627:therapeutic use*; D043373:Follicle Stimulating Hormone, Human; D006801:Humans; D007246:Infertility / Q000628:therapy; D011247:Pregnancy; D016032:Randomized Controlled Trials as Topic; D011994:Recombinant Proteins / Q000627:therapeutic use
chemical_list: D043373:Follicle Stimulating Hormone, Human; D011994:Recombinant Proteins; D005640:Follicle Stimulating Hormone